R H Weiss
Overview
Explore the profile of R H Weiss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
418
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen C, Fong L, Yu E, Wu R, Trott J, Weiss R
Oncogene
. 2017 Feb;
36(25):3588-3598.
PMID: 28166200
Targeted therapeutics, such as those abrogating hypoxia inducible factor (HIF)/vascular endothelial growth factor signaling, are initially effective against kidney cancer (or renal cell carcinoma, RCC); however, drug resistance frequently occurs...
2.
Weiss R, Lin P
Kidney Int
. 2006 Jan;
69(2):224-32.
PMID: 16408110
Kidney cancer, although relatively rare when compared to other malignancies, occurs not uncommonly in patients with renal disease and is often discovered incidentally during the initial nephrologic work-up, or by...
3.
Weiss R, HOWARD L
Cell Signal
. 2001 Oct;
13(10):727-33.
PMID: 11602183
p73 is a newly described homologue of the tumour suppressor p53 that was cloned serendipitously and subsequently shown to possess considerable homology in the most evolutionarily conserved p53 domains. Yet...
4.
Hupfeld C, Weiss R
Am J Physiol Endocrinol Metab
. 2001 Jul;
281(2):E207-16.
PMID: 11440895
The thiazolidenediones (TZDs) are commonly used to treat hyperglycemia in type 2 diabetes. Diabetes is associated with macrovascular disease, leading to accelerated atherosclerosis caused by aberrant vascular smooth muscle (VSM)...
5.
Weiss R, Randour C
Cell Signal
. 2000 Jul;
12(6):413-8.
PMID: 10889470
The cyclin-dependent kinase inhibitors (CKI) interact with cyclin-cdk complexes to arrest mitogen-stimulated transit through the cell cycle, but we and others have recently shown that these molecules can exert permissive...
6.
Weiss R, Joo A, Randour C
J Biol Chem
. 2000 Apr;
275(14):10285-90.
PMID: 10744715
The cyclin-dependent kinase inhibitors interact with cyclin-cdk complexes to arrest mitogen-stimulated transit through the cell cycle, but these proteins have recently been shown to have positive regulatory effects on cyclin-cdk...
7.
Weiss R, Ramirez A, Joo A
J Am Soc Nephrol
. 1999 Sep;
10(9):1880-90.
PMID: 10477139
Growth factor-stimulated DNA synthesis in a variety of cell lines has been shown to be decreased after overnight (or longer) treatment with the 3-hydroxy-3-methylglutaryl CoA reductase inhibitors, the statins. Although...
8.
Weiss R, Ramirez A
Nephrol Dial Transplant
. 1998 Nov;
13(11):2804-13.
PMID: 9829482
Background: Glomerulonephritis is characterized by the accumulation of extracellular matrix protein within the glomerulus. This process, when allowed to proceed unimpeded, leads to glomerulosclerosis and eventually to cessation of glomerular...
9.
Weiss R
Cell Signal
. 1998 Aug;
10(5):313-20.
PMID: 9692674
The kidney is responsible for regulation of water and electrolyte balance, filtration and absorption of plasma proteins, and control of blood volume and pressure. Homeostasis achieved by the kidney is...
10.
Weiss R, Maga E, Ramirez A
Am J Physiol
. 1998 Jun;
274(6):C1521-9.
PMID: 9696694
Proteins comprising the mitogen-activated protein (MAP) kinase signaling cascade are activated by a variety of growth factors, but the precise role of this series of kinase reactions, especially Raf kinase...